General Information of Drug (ID: DMXGF56)

Drug Name
US9598431, 5 Drug Info
Synonyms
SCHEMBL18609480; BDBM302861; BDBM302862; US9598431, 5; US9598431, 4; (5'S)-5-Methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]; tert-Butyl (5'S)-5'-methyl-4',5'-dihydro-1H-spiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-carboxylate
Cross-matching ID
PubChem CID
126669412
TTD Drug ID
DMXGF56

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9598431, 2 DMILY1P N. A. N. A. Patented [1]
US9598431, 1 DMRVQ5Z N. A. N. A. Patented [1]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
RAR-related orphan receptor-beta (RORB) TTGB2LZ RORB_HUMAN Inhibitor [1]

References

1 Compounds useful for inhibiting ROR-gamma-t. US9598431.
2 All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol. 2003 Oct;10(10):820-5.